» Articles » PMID: 36737453

Molecular Characterization and Antimicrobial Susceptibility Profiles of Thai Mycoplasma Synoviae Isolates

Overview
Journal Sci Rep
Specialty Science
Date 2023 Feb 3
PMID 36737453
Authors
Affiliations
Soon will be listed here.
Abstract

Mycoplasma synoviae (MS) infection is mainly controlled by pathogen-free flocks' maintenance, medication in infected flocks, and vaccination in high-risk flocks. The effective control strategy requires convenient approach for detecting and differentiating MS strains and reliable drug susceptible evidence for deciding on reasonable antimicrobial usage. This study aimed to characterize the partial vlhA gene of nine Thai MS isolates circulated in chickens in 2020, to verify the PCR-RFLP assay for strain differentiation, and to determine the eight antimicrobial susceptibility profiles using microbroth dilution method. Based on sequence analysis of the partial vlhA gene, Thai MS isolates in 2020 were classified as types E and L with 19 and 35 amino acid lengths, respectively. The developed PCR-RFLP assay could detect and differentiate vaccine and Thai field strains. Most Thai MS isolates in this study were susceptible to tylosin, tylvalosin, tiamulin, doxycycline, oxytetracycline, tilmicosin, and lincomycin-spectinomycin at MIC values of 0.0391, 0.0098, 0.0781, 0.1563, 0.1563, 0.625 and 0.625 μg/mL, respectively; and resistance to enrofloxacin at MIC value of 10 μg/mL. In conclusion, this study revealed diagnostic assays for differentiating MS strains and the antimicrobial susceptibility profiles of Thai MS, which are necessary to design suitable MS control procedures for poultry flocks.

Citing Articles

Pharmacokinetics of Tylvalosin Following Intravenous or Oral Administration at Different Doses in Broiler Chickens.

Wen Z, Chen S, Meng J, Wu Q, Yu R, Xu N Vet Sci. 2025; 12(2).

PMID: 40005878 PMC: 11861990. DOI: 10.3390/vetsci12020118.


The novel pleuromutilin derivative 22-((4-((4-nitrophenyl)acetamido)phenyl)thio)deoxy pleuromutilin possesses robust anti-mycoplasma activity both and .

Xia X, Ji X, Li Y, Wang Y, Zhao Y, Wang W Front Pharmacol. 2025; 15:1491223.

PMID: 39759447 PMC: 11695783. DOI: 10.3389/fphar.2024.1491223.

References
1.
Markham J, Scott P, Whithear K . Field evaluation of the safety and efficacy of a temperature-sensitive Mycoplasma synoviae live vaccine. Avian Dis. 1999; 42(4):682-9. View

2.
Landman W, Mevius D, Veldman K, Feberwee A . In vitro antibiotic susceptibility of Dutch Mycoplasma synoviae field isolates originating from joint lesions and the respiratory tract of commercial poultry. Avian Pathol. 2008; 37(4):415-20. DOI: 10.1080/03079450802216637. View

3.
Stipkovits L, Kempf I . Mycoplasmoses in poultry. Rev Sci Tech. 1996; 15(4):1495-525. DOI: 10.20506/rst.15.4.986. View

4.
Bencina D, Horvat S, Narat M, Kleven S, Dovc P . Molecular basis of the length variation in the N-terminal part of Mycoplasma synoviae hemagglutinin. FEMS Microbiol Lett. 2001; 203(1):115-23. DOI: 10.1111/j.1574-6968.2001.tb10829.x. View

5.
Lockaby S, Hoerr F, Lauerman L, Kleven S . Pathogenicity of Mycoplasma synoviae in broiler chickens. Vet Pathol. 1998; 35(3):178-90. DOI: 10.1177/030098589803500303. View